Brandywine Global Investment Management LLC Takes Position in Embecta Corp. (NASDAQ:EMBC)

Brandywine Global Investment Management LLC acquired a new position in shares of Embecta Corp. (NASDAQ:EMBC) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 195,768 shares of the company’s stock, valued at approximately $4,043,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Intech Investment Management LLC bought a new position in shares of Embecta during the third quarter valued at approximately $211,000. Rockefeller Capital Management L.P. boosted its position in Embecta by 3.7% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 90,072 shares of the company’s stock valued at $1,270,000 after purchasing an additional 3,231 shares during the period. Verition Fund Management LLC grew its stake in Embecta by 45.3% during the 3rd quarter. Verition Fund Management LLC now owns 17,682 shares of the company’s stock worth $249,000 after buying an additional 5,511 shares during the last quarter. Quarry LP acquired a new stake in Embecta in the third quarter worth $30,000. Finally, Jane Street Group LLC lifted its stake in Embecta by 156.1% in the third quarter. Jane Street Group LLC now owns 176,487 shares of the company’s stock valued at $2,488,000 after buying an additional 107,567 shares during the last quarter. Institutional investors and hedge funds own 93.83% of the company’s stock.

Insider Transactions at Embecta

In other news, Director Milton Mayo Morris sold 3,100 shares of Embecta stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total transaction of $50,778.00. Following the transaction, the director now directly owns 36,133 shares in the company, valued at approximately $591,858.54. This trade represents a 7.90 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.42% of the company’s stock.

Embecta Stock Performance

Embecta stock opened at $12.63 on Wednesday. Embecta Corp. has a one year low of $9.93 and a one year high of $21.48. The company has a 50-day simple moving average of $15.02 and a 200-day simple moving average of $16.23. The firm has a market capitalization of $734.23 million, a P/E ratio of 12.63, a P/E/G ratio of 0.78 and a beta of 1.27.

Embecta (NASDAQ:EMBC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.20. Embecta had a negative return on equity of 19.22% and a net margin of 5.25%. As a group, sell-side analysts forecast that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.75%. Embecta’s dividend payout ratio (DPR) is 60.00%.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.